Principal Investigator
GlaxoSmithKline
Keegan Orzechowski is a Principal Investigator in the Drug Substance Process Development Department at GSK, Upper Merion. He holds a B.S. in Biotechnology from The Pennsylvania State University. Since joining GSK, Keegan has worked throughout commercial manufacturing, pilot plant, and development spaces and co-authored 2 research papers. For the last 13 years he has worked in microbial and mammalian upstream process development including optimization and characterization of dAbs and mAbs with a focus on metabolomics. Keegan is currently working on optimizing perfusion media for continuous processing using ATF technology.